What is Arborlight?
Arborlight is at the forefront of developing and manufacturing a unique lighting system designed to replicate natural daylight. This proprietary Daylight Emulation technology is engineered for diverse applications, including medical facilities, architectural projects, office environments, and scientific apparatus. By mimicking the sun's effects on human circadian rhythms, Arborlight's luminaires aim to foster healthier and more productive settings, directly contributing to workplace well-being and safety. The company's focus on bio-adaptive lighting positions it as a key innovator in the smart building and health technology sectors.
How much funding has Arborlight raised?
Arborlight has raised a total of $2.3M across 2 funding rounds:
Private Equity
$1.8M
Angel/Seed
$502K
Private Equity (2015): $1.8M with participation from The Michigan Angel Fund
Angel/Seed (2016): $502K, investors not publicly disclosed
Key Investors in Arborlight
The Michigan Angel Fund
The Michigan Angel Fund is a professionally managed angel fund dedicated to financing early-stage companies within Michigan, aiming to stimulate the state's entrepreneurial ecosystem. They focus on connecting angel capital with local businesses, fostering collaboration and success among entrepreneurs and investors.
What's next for Arborlight?
The recent major strategic investment signifies a critical juncture for Arborlight, likely enabling the company to scale its manufacturing capabilities, expand its market reach, and further invest in research and development. Given the enterprise-level context of its total funding, Arborlight appears poised for significant growth, potentially exploring new application verticals or enhancing its existing product lines. This capital infusion is expected to accelerate its mission to integrate healthier, more naturalistic lighting solutions into mainstream commercial and specialized environments, solidifying its position as a leader in circadian-effective illumination.
See full Arborlight company page
